| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBSTF | Common Shares | Sale | $17,000 | -50,000 | -0.24% | $0.3400 | 21,127,075 | 28 Nov 2023 | Held by Vita Holdings LLC | F1, F5 |
| transaction | CBSTF | Common Shares | Sale | $33,000 | -100,000 | -0.47% | $0.3300 | 21,027,075 | 28 Nov 2023 | Held by Vita Holdings LLC | F2, F5 |
| transaction | CBSTF | Common Shares | Sale | $17,000 | -50,000 | -0.24% | $0.3400 | 20,977,075 | 29 Nov 2023 | Held by Vita Holdings LLC | F3, F5 |
| transaction | CBSTF | Common Shares | Sale | $17,000 | -50,000 | -0.24% | $0.3400 | 20,927,075 | 29 Nov 2023 | Held by Vita Holdings LLC | F4, F5 |
| holding | CBSTF | Common Shares | 618,950 | 28 Nov 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3581 = US$1.00. |
| F2 | The sales price reported above was converted from the Canadian sales price of C$0.45 using an exchange rate of C$1.3581 = US$1.00. |
| F3 | The sales price reported above was converted from the Canadian sales price of C$0.46 using an exchange rate of C$1.3590 = US$1.00. |
| F4 | The sales price reported above was converted from the Canadian sales price of C$0.465 using an exchange rate of C$1.3590 = US$1.00. |
| F5 | Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes. |